Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial von Kanakura, Yuzuru, Ohyashiki, Kazuma, Shichishima, Tsutomu, Okamoto, Shinichiro, Ando, Kiyoshi, Ninomiya, Haruhiko, Kawaguchi, Tatsuya, Nakao, Shinji, Nakakuma, Hideki, Nishimura, Jun-ichi, Kinoshita, Taroh, Bedrosian, Camille L., Valentine, Marye Ellen, Khursigara, Gus, Ozawa, Keiya, Omine, Mitsuhiro

Volltext

Effect of novel peptide vaccines on secondary recurrences and survivorship von Valentine, Marye Ellen, Chance, Lacey, Gompper, Peter Todd, Choy, Gavin S.

Volltext

Procedural and late outcomes following MULTI-LINK DUET coronary stent deployment von Kereiakes, Dean J, Midei, Mark, Hermiller, James, O’Shaughnessy, Charles, Schlofmitz, Richard, Yakubov, Steven, Fink, Stan, Hu, Frank, Nishimura, Naomi, Sievers, Marina, Valentine, Marye Ellen, Broderick, Thomas, Lansky, Alexandra, Moses, Jeffrey

Volltext

Chronic Renal Insufficiency in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Improvement with Eculizumab Treatment in the Long-Term Follow-up of the AEGIS Study von Kanakura, Yuzuru, Ohyashiki, Kazuma, Shichishima, Tsutomu, Okamoto, Shinichiro, Ando, Kiyoshi, Ninomiya, Haruhiko, Kawaguchi, Tatsuya, Nakao, Shinji, Nakakuma, Hideki, Nishimura, Jun-ichi, Kinoshita, Taroh, Bedrosian, Camille, Valentine, Marye Ellen, Ozawa, Keiya, Omine, Mitsuhiro

Volltext

Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria: AEGIS Phase II Clinical Study Results von Kanakura, Yuzuru, Ohyashiki, Kazuma, Shichishima, Tsutomu, Okamoto, Shinichiro, Ando, Kiyoshi, Ninomiya, Haruhiko, Kawaguchi, Tatsuya, Nakao, Shinji, Nakakuma, Hideki, Nishimura, Jun-Ichi, Kinoshita, Taroh, Bedrosian, Camille, Valentine, Marye Ellen, Ozawa, Keiya, Omine, Mitsuhiro

Volltext